Core Viewpoint - The company Fulejia (301371) has announced that its Class III medical device, "Recombinant Type III Humanized Collagen Dressing," has passed ethical review for clinical trials and has been registered with the Heilongjiang Provincial Drug Administration, entering the clinical trial phase [1] Group 1: Product Development - The product is intended for auxiliary treatment of wound repair after laser and photon procedures, as well as for repairing skin barrier function damage in sensitive skin patients [1] - The product has completed the necessary ethical review and registration, indicating progress in its development [1] Group 2: Market Potential - There are relatively few similar medical devices and manufacturers in the aesthetic medicine field, suggesting a growing market with significant potential [1] - The domestic production and sales of similar products are increasing rapidly, reflecting a sustained growth in market demand [1]
敷尔佳：第三类医疗器械产品完成临床试验备案